Market revenue in 2023 | USD 0.3 million |
Market revenue in 2030 | USD 0.6 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 33.33% in 2023. Horizon Databook has segmented the Kuwait 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
In Kuwait, the growing interest and rising investment in healthcare technology & innovation are among the factors significantly driving the 3D printed drugs market. Kuwait is progressively embracing cutting edge technologies to enhance its healthcare sector, and 3D printing presents a compelling opportunity to revolutionize drug manufacturing and personalized medicine.
Moreover, Kuwait’s Vision 2035 aims to diversify the country’s healthcare ecosystem by introducing private players in healthcare services. The strategic location of Kuwait in the Middle East positions the nation as a potential hub for healthcare innovation, attracting regional and international collaborations.
Moreover, the commitment to diversifying the economy beyond oil has led to a focus on investing in sectors such as healthcare and technology, further propelling the adoption of advanced manufacturing technologies, including 3D printing, in drug production. Furthermore, Kuwait's robust infrastructure and supportive regulatory environment contribute to the growth of the 3D printed drugs market.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account